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Objective: This study aims to investigate the hepatotoxicity of metoprolol and find a prophylactic way to protect the liver through the use of Vitamin E.
Methods: A total of 18 male rabbits were divided randomly into three groups, with six in each group. Group I (control) received corn oil, Group II 
was treated with metoprolol (20 mg/kg), and Group III was treated with Vitamin E (175 mg/kg) 30 min before metoprolol treatment. All treatments 
were given orally and daily for 14 days; animals were sacrificed at day 15. Biochemical parameters were estimated, and the liver was used for 
histopathological examinations.
Results: Histopathological changes of liver injury were found in all metoprolol-treated rabbits, while these changes were minimized in all rabbits who 
were given Vitamin E. Serum liver function tests and malondialdehyde (MDA) were significantly elevated after metoprolol treatment and returned 
close to the control value on prior treatment with Vitamin E. Serum MDA, aspartate aminotransferase, and alanine aminotransferase were significantly 
decreased following treatment with Vitamin E.
Conclusion: Vitamin E may have a hepatoprotective effect against metoprolol-induced liver injury in rabbits.
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INTRODUCTION
Drug-induced liver injury is a well-known adverse effect of numerous 
medications, with clinical presentation ranging from an elevation of 
asymptomatic liver enzymes through to liver failure [1]. A cardioselective 
beta1-adrenergic blocking agent, metoprolol, is used to treat a number 
of conditions including angina pectoris, acute myocardial infarction, 
heart failure, tachyarrhythmias, and mild-to-moderate hypertension, 
as well as being used as prophylaxis for migraine headaches [2,3]. 
Inactive metabolites are generated when metoprolol is metabolized 
as it undergoes α-hydroxylation and O-demethylation as an enzyme 
substrate of the cytochrome liver enzyme CYP2D6 and a small 
percentage by CYP3A4 [4]. CYP2D6 activity is notably variable among 
individuals due to the polymorphism of the CYP2D6 gene, so the plasma 
concentrations of metoprolol in poor metabolizers are several times 
higher than those found in extensive metabolizers [5].
Metoprolol has been linked to some clinical cases of drug-induced liver 
injury, with the first case report of metoprolol hepatotoxicity being 
reported in 1989. In this case, an elderly woman developed fatigue 
and abdominal pain 2 weeks after starting metoprolol (50 mg daily) 
for migraine headaches. Laboratory tests showed marked elevations 
in serum aminotransferase, while a liver biopsy revealed occasional 
ballooned hepatocytes without inflammation or fibrosis, together with 
moderate steatosis [6]. In 2017, Cyriac Philips reported the case of a 
young woman who was left with severe acute liver injury, jaundice, and 
Grade 1 hepatic encephalopathy following 8 weeks of metoprolol use to 
treat acute myocardial infarction. All the reported cases confirmed that 
liver injury gradually disappeared and liver test results improved when 
metoprolol was discontinued [7].
Antioxidant vitamins such as Vitamin C and Vitamin E play a key role 
in regulating a wide range of pathological and physiological processes. 
As well as enhancing the immune system and generating free radical 
scavenging properties, antioxidant vitamins are also involved with the 
alteration of cell proliferation and the modification of the carcinogen 
metabolism [8,9]. As a primary liposoluble antioxidant, Vitamin E 
is thought to play a pivotal role in scavenging free oxygen radicals 
and stabilizing cell membranes, which allows cell permeability to 
be maintained [10]. In addition, this critical vitamin has a defensive 
role in that it minimizes the harmful effects of oxidation that causes 
damage to the liver and other body parts [11]. Furthermore, Vitamin E 
has a notably positive effect on cell membranes as it has the effect of 
protecting the polyunsaturated fats within them, therefore, preserving 
the structure and function of the membranes [12].
In the present study, oxidative stress has been addressed as a mechanism 
that may be responsible for metoprolol-induced liver injury. However, 
no studies to date have studied the potentially protective nature of 
Vitamin E with regard to mitigating metoprolol-induced liver damage. 
Therefore, the author selected exogenous Vitamin E to evaluate its 
protective effects on metoprolol-induced liver injury in rabbits.
MATERIALS AND METHODS
Chemicals and their preparation
Metoprolol as metoprolol succinate tablet (50 mg) was purchased 
from AstraZeneca, Switzerland. An accurate dose of 20 mg/kg was 
administered orally for each rabbit through a stainless steel feeding 
tube. Vitamin E as d-alpha tocopheryl acetate powder was purchased 
from Bulk Supplement.com, Henderson, USA. Using a standard 
measuring spoon, 175 mg of Vitamin E was accurately measured and 
dissolved in 1 ml of corn oil to prepare an accurate dose of 175 mg/kg.
Animals
The experiment was carried out on 18 locally bred, 9-month-old 
domestic male rabbits weighing 1–2 kg. The animals were housed in the 
animal house at Basra College of Pharmacy; they were kept in stainless 
steel cages for acclimatization, with free access to food and water and 
a 12:12-h cycle of light and darkness. The animals were not fed for 
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12 hours before the experiment. The study was approved by the Local 
Institutional Ethical Committee of the Faculty of Pharmacy College at 
the University of Basra.
Study protocol
The study was carried out between January and April 2018. The rabbits 
were randomly divided into three groups, with six animals in each 
group, as follows:
• Group I: Served as the control group, received 1 ml of corn oil daily 
for 14 days.
• Group II: Treated with a single oral dose of metoprolol (20 mg/kg/d) 
for 14 days.
• Group III: Pre-treated with Vitamin E (175 mg/kg/d) orally, 30 min 
before metoprolol treatment.
On the 15th day of drug administration, the animals were anesthetized 
under light ether anesthesia. Blood was taken directly from the heart 
and transferred into a non-heparinized tube; then, the serum was 
separated through centrifugal spinning for 20 min at 3000 rpm. 1 ml 
of serum was taken for serum malondialdehyde (MDA) measurement 
and the remainder was frozen at −20°C for the analysis of liver function 
test (LFT) measurements. The rabbits were then sacrificed, and liver 
specimens were taken for histopathological examination.
Laboratory measurements
Determination of the serum MDA level: Thiobarbituric acid assay of 
Buege and Aust (1978) was used for measuring serum MDA [13].
LFT: The activities of aspartate aminotransferase (AST), alanine 
aminotransferase (ALT), alkaline phosphatase (ALP), and total bilirubin 
in serum were estimated by an autoanalyzer (Biochemistry Analyzer, 
Integra 400 Plus, Roche, Germany), by selecting the already coded 
program in the analyzer for all samples.
Histopathological examination
The livers were carefully removed and washed with 0.9% saline 
solution. The liver specimens were kept in 10% formalin and embedded 
in paraffin wax before being cut into 5 μm slices. The slices were 
stained with hematoxylin and eosin (H and E); then, the specimens 
were examined by a specialist histopathologist at the Department 
of Pathology and Forensic Medicine, College of Medicine, Basra. The 
examiner was blind for the treatments.
Statistical analysis
The results were expressed as mean ± standard deviation. The data 
were statistically evaluated using ordinary one-way analysis of variance 
followed by Tukey’s multiple comparisons test using GraphPad Prism 8 
computer software. The results were considered statistically significant 
at p<0.05.
RESULTS
Effect of treatments on serum liver enzymes
In Table 1, it is shown that metoprolol treatment produced significant 
elevation (p<0.01) in the levels of ALT, AST, and ALP, compared to the 
control group. Pre-treatment with Vitamin E significantly (p<0.01) 
decreased ALT and AST levels, while the reduction in the ALP level 
did not achieve statistical significance compared with the value of 
metoprolol treatment (p=0.6).
Effect of treatments on serum total bilirubin
The serum total bilirubin in the control group was significantly 
increased (p<0.01) by metoprolol treatment, then decreased by 
Vitamin E; this reduction was statistically insignificant (p=0.17) as 
presented in Table 1.
Effect of treatments on serum MDA
The serum level of MDA significantly increased (p<0.0001) in the group 
treated with metoprolol compared with the control group. As illustrated 
in Table 1, treatment with Vitamin E before metoprolol significantly 
reduced the MDA level (p<0.0001).
Histopathological examination
Control group
None of the liver samples obtained from rabbits in this group showed 
any histopathological changes (n=6). A representative histopathological 
slide is presented in Fig. 1a.
Metoprolol group
All of the rabbits in the experiment demonstrated significant liver 
injury after the metoprolol challenge; in all rabbits, the liver showed 
severe hydropic degeneration, perivenular sinusoidal dilatation, 
and moderate-to-severe inflammation represented by lymphocytic 
infiltration (portal and lobular) (Fig. 1b and c).
Metoprolol+Vitamin E group
Histopathological examination showed amelioration of metoprolol-
induced liver injury in all the rabbits that had been pre-treated with 
Vitamin E. All these rabbits’ livers showed hydropic degeneration that 
ranged from mild to moderate. Mild perivenular sinusoidal dilatation 
was seen in three rabbits, while two rabbits were found to have 
mild inflammatory cell infiltration of lymphocytes in the portal area 
(Fig. 1d and inset).
DISCUSSION
As a beta-blocker, metoprolol is used in the treatment of angina, heart 
failure, and hypertension [14]. While metoprolol therapy has been 
associated with a low rate of mild-to-moderate elevation of the level 
of serum liver enzymes, these are usually asymptomatic. When liver 
injury occurs due to metoprolol therapy, this varies in severity and 
ranges from mild serum aminotransferase elevations to mild acute 
hepatitis with jaundice [6].
The mechanism behind metoprolol-induced liver injury is unknown, 
but in the present study, the oxidative stress mechanism is implicated 
in the pathogenesis of certain injury induced by metoprolol. This is 
because the susceptibility of an organ to oxidative stress is a role of the 
overall balance between the factors that induce oxidative stress and 
those that exhibit antioxidant capability [15].
MDA concentrations always increase with elevated lipid 
peroxidation [16], and this experiment determined to investigate 
whether metoprolol caused oxidative damage. The significant 
elevation of MDA following the introduction of metoprolol indicates 
that it is possible that metoprolol interacts with vital subcellular sites 
including the mitochondria cytosol and peroxisomes, which results 
Table 1: Effect of Vitamin E on serum hepatic marker enzymes, total bilirubin, and MDA in metoprolol‑induced liver injury in rabbits
Groups ALT (U/L) AST (U/L) ALP (U/L) TB (mg/dl) MDA (µmol/l)
Control 32.01±4.70 22.05±4.04 89.06±3.57 0.883±0.25 0.341±0.05
Metoprolol 45.68±5.22 41.68±5.53 111.8±12.21 1.616±0.41 0.783±0.05
Metoprolol + Vitamin E 33.63±5.21** 25±5.72** 106.8±11.78 1.25±0.32 0.516±0.04***
n=6, Data expressed as mean±SD. P value significantly different from the metoprolol value, **p<0.01, ***p<0.0001. ALT: Alanine aminotransferase, AST: Aspartate 
aminotransferase, ALP: Alkaline phosphatase, TB: Total bilirubin, MDA: Malondialdehyde, SD: Standard deviation
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in the generation of extreme amounts of free radicals. These free 
radicals generate oxidative damage to biomolecules such as lipids 
and proteins, which causes oxidative stress and may contribute to 
various pathophysiological changes including hydropic degeneration 
of hepatocytes. Lipid peroxidation is one of the main manifestations 
of metoprolol-induced oxidative damage. It is possible that the 
significant increase in the level of serum MDA in metoprolol-treated 
rabbits could be due to excessive formation of free radicals, which 
leads to the deterioration of biological macromolecules [17]. Vitamin E 
(175 mg/kg) recovers the body’s antioxidant capacity and protects the 
liver by decreasing lipid peroxidation, represented by the significant 
reduction in serum MDA. These findings provide a theoretical basis 
for the prevention of toxicity caused by metoprolol, which may benefit 
humans.
The alterations in the hepatocytes after exposure to metoprolol in 
this study were mainly hydropic change and cellular edema. Hydropic 
change is an acute reversible change resulting from non-lethal injuries; 
it is an intracytoplasmic accumulation of water due to the incapacity 
of the cells to maintain the fluid and ionic homeostasis [18]. This can 
be clearly observed in the livers shown in Fig. 1b and c. Metoprolol 
may induce hydropic change indirectly through the release of 
extremely reactive and toxic free radicals. These free radicals cause 
lipid peroxidation, as well as cell membrane damage, with the cellular 
swelling resulting from an inundation of sodium and water. Metoprolol 
treatment in the rabbits appeared to cause the vacuolated swelling of 
the cytoplasm in the hepatocytes, which may be indicative of an acute 
liver injury.
Several previous experimental research studies on animal species have 
demonstrated that Vitamin E treatment ameliorated liver injury that 
had been induced by exposure to carbon tetrachloride [19], doxorubicin, 
anthracycline antibiotic [20], azathioprine [21], and pesticides such as 
malathion [22]. In addition, many studies have proved that Vitamin E 
supplements can decrease steatosis, inflammation, and cell injury in 
patients with non-alcoholic fatty liver disease. Furthermore, the antioxidant 
effect of Vitamin E may reduce liver damage caused by oxidation [23].
Oral pre-treatment with Vitamin E (175 mg/kg) 30 min before daily 
metoprolol administration was reported to ameliorate histopathological 
changes. Investigators demonstrated that the mechanisms underlying 
the amelioration of liver injury by Vitamin E appeared to be related 
not only to the prevention of liver cell deterioration but also to 
the maintenance of membrane integrity. The molecules of the 
Vitamin E family exert anti-inflammatory activities [23]. Therefore, liver 
inflammation either changed to mild following Vitamin E treatment or 
disappeared entirely.
The elevation in the serum levels of hepatic marker enzymes and total 
bilirubin was attributed to damaged liver cells since hepatic enzymes 
are located in the cytosol and released into the blood following liver 
damage [24,25]. After Vitamin E administration, there was a reduction 
in lipid peroxidation and the integrity of hepatocytes was maintained, 
while there was less leakage of liver enzymes from hepatocytes. This led 
to decreased serum enzymes levels, particularly ALT and AST. The non-
significant reduction in total bilirubin agreed with many other studies 
that have described the beneficial effect of Vitamin E on liver function. 
It is likely that this is related to a reduction in red cell hemolysis and 
enhancement of bilirubin conjugation [26-29].
CONCLUSION
The results of the current study revealed that metoprolol 
(20 mg/kg/d for 14 days) caused lipid peroxidation, significant elevation 
in the serum liver enzymes, and histopathological changes in the liver. 
Supplementation with Vitamin E exhibited a moderate protective effect. 
The appearance of hepatocytes after metoprolol treatment suggests that 
metoprolol interacts indirectly with the hepatic tissue by interfering 
with the antioxidant defense mechanism, leading to reactive oxygen 
species generation. In turn, this may induce stress in the hepatocytes, 
which undergo severe hydropic degeneration, perivenular sinusoidal 
dilatation, and moderate-to-severe inflammation.
Vitamin E (175 mg/kg half an hour before metoprolol) significantly 
reduced the serum levels of ALT, AST, and MDA. In addition, Vitamin E 
showed mild-to-moderate hydropic degeneration of all rabbits’ livers 
and mild inflammation in two rabbits only, while it improved the hepatic 
histopathological damage induced by metoprolol. Moreover, the free 
radical scavenging activity of Vitamin E decreased lipid peroxidation 
and thus oxidative stress, and it, therefore, exerted protection against 
metoprolol-induced liver injury.
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